Evidence map›Paper›PMID 16093397›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2005

Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor.

Natsuko Tsujino, Akihiro Yamanaka, Kanako Ichiki, Yo Muraki, Thomas S Kilduff, Ken-ichi Yagami, Satoru Takahashi, Katsutoshi Goto, Takeshi Sakurai

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 142 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Neurolysin Knockout Mice in a Diet-Induced Obesity Model.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. A Perspective of Epigenetic Regulation in Radiotherapy.Frontiers in cell and developmental biology · 2021
    Review
  9. Heterogeneity of Hypocretin/Orexin Neurons.Frontiers of neurology and neuroscience · 2021
    Review
  10. Article
  11. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Orexin System: The Key for a Healthy Life.Frontiers in physiology · 2017
    Review
  17. Orexin/Hypocretin System: Role in Food and Drug Overconsumption.International review of neurobiology · 2017
    Review
  18. Review
  19. Review
  20. Fluorescence Lifetime Imaging of Apoptosis.Tomography (Ann Arbor, Mich.) · 2015
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Natsuko TsujinoDepartment of Molecular Pharmacology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Akihiro Yamanaka
Kanako Ichiki
Yo Muraki
Thomas S Kilduff
Ken-ichi Yagami
Satoru Takahashi
Katsutoshi Goto
Takeshi Sakurai
University of Tsukuba · JPJapan Science and Technology Agency · JPSRI International · US

Funding

NEURAL GENE EXPRESSION IN SLEEP DEPRIVATION AND RECOVERYR01HL059658 · NHLBI · STANFORD UNIVERSITY · PI KILDUFF, THOMAS S · 1997 to 2023
$8.7M
NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDER01MH061755 · NIMH · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 1999 to 2007
$3.0M
SLEEP, AGING, AND THE HYPOCRETIN/OREXIN SYSTEMR01AG020584 · NIA · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 2003 to 2007
$2.3M
NHLBI NIH HHS R01 HL059658NIA NIH HHS R01 AG020584NIA NIH HHS R01AG020584NIMH NIH HHS R01 MH061755NIMH NIH HHS R01MH61755
6 · The paper itself

Abstract

Orexin A and B are neuropeptides implicated in the regulation of sleep/wakefulness and energy homeostasis. The regulatory mechanism of the activity of orexin neurons is not precisely understood. Using transgenic mice in which orexin neurons specifically express yellow cameleon 2.1, we screened for factors that affect the activity of orexin neurons (a total of 21 peptides and six other factors were examined) and found that a sulfated octapeptide form of cholecystokinin (CCK-8S), neurotensin, oxytocin, and vasopressin activate orexin neurons. The mechanisms that underlie CCK-8S-induced activation of orexin neurons were studied by both calcium imaging and slice patch-clamp recording. CCK-8S induced inward current in the orexin neurons. The CCKA receptor antagonist lorglumide inhibited CCK-8S-induced activation of orexin neurons, whereas the CCKB receptor agonists CCK-4 (a tetrapeptide form of cholecystokinin) and nonsulfated CCK-8 had little effect. The CCK-8S-induced increase in intracellular calcium concentration was eliminated by removing extracellular calcium but not by an addition of thapsigargin. Nifedipine, omega-conotoxin, omega-agatoxin, 4-ethylphenylamino-1,2-dimethyl-6-methylaminopyrimidinium chloride, and SNX-482 had little effect, but La3+, Gd3+, and 2-aminoethoxydiphenylborate inhibited CCK-8S-induced calcium influx. Additionally, the CCK-8S-induced inward current was dramatically enhanced in the calcium-free solution and was inhibited by the cation channel blocker SKF96365, suggesting an involvement of extracellular calcium-sensitive cation channels. CCK-8S did not induce an increase in intracellular calcium concentration when membrane potential was clamped at -60 mV, suggesting that the calcium increase is induced by depolarization. The evidence presented here expands our understanding of the regulation of orexin neurons and the physiological role of CCK in the CNS.

Indexed as

AnimalsCalciumCholecystokininElectric ConductivityExcitatory Postsynaptic PotentialsExtracellular FluidFemaleFluorescent Antibody TechniqueIntracellular Signaling Peptides and ProteinsIn Vitro TechniquesLuminescent ProteinsMaleMiceMice, TransgenicNeural InhibitionNeurons8-sulfocholecystokinin octapeptideCalciumCholecystokininHCRT protein, humanIntracellular Signaling Peptides and ProteinsLuminescent ProteinsNeuropeptidesOrexin ReceptorsOrexinsReceptor, Cholecystokinin AReceptors, G-Protein-CoupledReceptors, NeuropeptideRecombinant Fusion ProteinsRecombinant ProteinsSincalideYcam-2 fluorescent proteinyellow cameleon 2.1

Identifiers

PMID16093397
PMCPMC6725310
OpenAlexW2058489268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.